These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 38319084

  • 1. KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97.
    Sanz MB, Pasteran F, de Mendieta JM, Brunetti F, Albornoz E, Rapoport M, Lucero C, Errecalde L, Nuñez MR, Monge R, Pennini M, Power P, Corso A, Gomez SA.
    Microbiol Spectr; 2024 Mar 05; 12(3):e0411123. PubMed ID: 38319084
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis.
    Shen S, Tang C, Yang W, Ding L, Han R, Shi Q, Guo Y, Yin D, Hu F.
    Emerg Microbes Infect; 2024 Dec 05; 13(1):2356146. PubMed ID: 38743401
    [Abstract] [Full Text] [Related]

  • 5. Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates.
    Pariona JGM, Vásquez-Ponce F, Becerra J, Martins-Gonçalves T, Pariona EMM, Madueño FT, Esposito F, V de Lima A, Mello Sampaio JL, Galhardo RS, Lincopan N.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0117324. PubMed ID: 39190636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam.
    Guzmán-Puche J, Pérez-Nadales E, Pérez-Vázquez M, Causse M, Gracia-Ahufinger I, Mendez-Natera A, Allalou-Ruiz Y, Elías C, Oteo-Iglesias J, Torre-Cisneros J, Martínez-Martínez L.
    Int J Antimicrob Agents; 2022 Feb 03; 59(2):106524. PubMed ID: 35038557
    [Abstract] [Full Text] [Related]

  • 11. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M, Castillo-Polo JA, Cordero DG, Pérez-Viso B, García-Castillo M, Saez de la Fuente J, Morosini MI, Cantón R, Ruiz-Garbajosa P.
    J Clin Microbiol; 2022 Mar 16; 60(3):e0224521. PubMed ID: 35107303
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility evaluation of novel beta-lactam/beta-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in hospitalized patients in Brazil.
    Wilhelm CM, Antochevis LC, Magagnin CM, Arns B, Vieceli T, Pereira DC, Lutz L, de Souza ÂC, Dos Santos JN, Guerra RR, Medeiros GS, Santoro L, Falci DR, Rigatto MH, Barth AL, Martins AF, Zavascki AP.
    J Glob Antimicrob Resist; 2024 Sep 16; 38():247-251. PubMed ID: 38936472
    [Abstract] [Full Text] [Related]

  • 15. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy.
    Piazza A, Mattioni Marchetti V, Bielli A, Biffignandi GB, Piscopiello F, Giudici R, Tartaglione L, Merli M, Vismara C, Migliavacca R.
    J Microbiol Immunol Infect; 2024 Jun 16; 57(3):457-469. PubMed ID: 38584042
    [Abstract] [Full Text] [Related]

  • 16. Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant Klebsiella pneumoniae Strains.
    Wu Y, Yang X, Liu C, Zhang Y, Cheung YC, Wai Chi Chan E, Chen S, Zhang R.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0265521. PubMed ID: 35416703
    [Abstract] [Full Text] [Related]

  • 17. Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.
    Shen S, Tang C, Ding L, Han R, Yin D, Yang W, Guo Y, Hu F.
    mSphere; 2022 Dec 21; 7(6):e0048722. PubMed ID: 36374086
    [Abstract] [Full Text] [Related]

  • 18. Multiple Novel Ceftazidime-Avibactam-Resistant Variants of blaKPC-2-Positive Klebsiella pneumoniae in Two Patients.
    Shi Q, Han R, Guo Y, Yang Y, Wu S, Ding L, Zhang R, Yin D, Hu F.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0171421. PubMed ID: 35588280
    [Abstract] [Full Text] [Related]

  • 19. Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between blaKPC-2 and blaKPC-145 during treatment of Klebsiella pneumoniae infection.
    Chen Y, Yang R, Guo P, Liu P, Deng J, Wu Z, Wu Q, Huang J, Liao K.
    Front Cell Infect Microbiol; 2023 Jun 29; 13():1244511. PubMed ID: 37671146
    [Abstract] [Full Text] [Related]

  • 20. Double blaKPC-2 copies quadrupled minimum inhibitory concentration of ceftazidime-avibactam in hospital-derived Klebsiella pneumoniae.
    Hu D, Wang S, Xu M, Zhang J, Luo X, Zhou W, Ma Q, Ma X.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0033124. PubMed ID: 38984824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.